Herbert J, Roser B
Transplantation. 1987 Apr;43(4):556-60. doi: 10.1097/00007890-198704000-00020.
Using PVG-RT1av1 neonatal heart grafts transplanted to the plantar space in irradiated PVG recipients, and adoptive transfer of normal and immune cells, we have analyzed the role of lymphocyte subsets in graft rejection. This assay was found to be reproducible and to show good dose-response characteristics, permitting a precise analysis of the potency of the cells transferred. Immune cells were 36 times more potent than normal cells and all of their activity was in the T cell fraction. The increase in potency of immune populations was entirely within the CD8+ population defined by the mouse monoclonal antibody MRC OX-8. The CD4+ population, defined by the antibody W3/25, in both normal and immune populations, restored first-set rejection. All the graft rejection activity of CD4+ cells could be ascribed to the MRC OX-22- subset of these cells.
利用移植到经辐照的PVG受体足底空间的PVG-RT1av1新生心脏移植物,以及正常细胞和免疫细胞的过继转移,我们分析了淋巴细胞亚群在移植物排斥反应中的作用。该检测方法具有可重复性,并显示出良好的剂量反应特性,能够精确分析所转移细胞的效力。免疫细胞的效力比正常细胞高36倍,其所有活性都在T细胞部分。免疫群体效力的增加完全在由小鼠单克隆抗体MRC OX-8定义的CD8+群体内。由抗体W3/25定义的CD4+群体,在正常群体和免疫群体中,都恢复了初次排斥反应。CD4+细胞的所有移植物排斥活性都可归因于这些细胞的MRC OX-22-亚群。